Clinical Trials Browser

Colorectal Neoplasms

Advanced Microsatellite Stable Colorectal Cancer

Liver Neoplasms

Adenocarcinoma Of Esophagus, Barrett Esophagus

Carcinoma, Hepatocellular, Liver Neoplasms

Stomach Neoplasms

Colorectal Neoplasms

Digestive System Neoplasms, Fatty Liver, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

Biliary Tract Neoplasms, Carcinoma, Hepatocellular

Colorectal Neoplasms

Colorectal Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms

Microsatellite-stable Colorectal Cancer

Biliary Tract Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Colorectal Neoplasms

Carcinoma, Hepatocellular

Colorectal Neoplasms

Rectal Neoplasms, Colorectal Neoplasms

Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Ras-mutated Metastatic Colorectal Cancer

Carcinoma, Hepatocellular

Colonic Neoplasms, Colorectal Neoplasms

Biliary Tract Neoplasms, Carcinoma, Hepatocellular

Carcinoma, Hepatocellular

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Rectal Neoplasms Malignant

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

pMMR/MSS Locally Advanced Rectal Cancer

Colonic Neoplasms, Rectal Neoplasms

Neoplasm Metastasis, Colorectal Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Cancer Metastatic

Carcinoma, Hepatocellular

Colorectal Cancer Metastatic

Colorectal Neoplasms

Carcinoma, Hepatocellular

Clinical Trials

AndroMETa-CRC

Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer

A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer

SLURP

A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma

Toco-CoR

Kirros

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma

Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

EMERALD-Y90

Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma

SCOTI

A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer

TERTIO

A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer

DEL-LIVER

An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)

Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients

A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

A Study of Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma

CHIMERA

TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study

INAVO-CRC

A Clinical Study on the Treatment of Metastatic Colorectal Cancer at the Second-line or Beyond.

Early-Line Anti-EGFR Therapy to Facilitate Retreatment for Select Patients With mCRC

BBOpCo

CAPOX and Bevacizumab With or Without Primary Tumor Radiotherapy and Iparomlimab and Tuvonralimab as First-line Treatment for RAS-Mutant/MSS Metastatic Rectal Cancer

RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC

ROMANCE - GOIM

COLIBRI-GI

Short-course Radiotherapy Followed by Sequential Chemotherapy With or Without PD-1 Monoclonal Antibody and Bevacizumab as Total Neoadjuvant Therapy in pMMR/MSS Locally Advanced Rectal Cancer （SPARK）

Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

CANTOR

A Single-center, Phase II Study on Efficacy & Safety of SCRT+CAPOX+Serplulimab+Bevacizumab for MSS Rectal Cancer

Gossypol Acetate + FOLFIRI + Bev in mCRC With TP53-Mutant and LRPPRC Positive

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

A Single-arm, Single-center, Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Bevacizumab and Standard Chemotherapy as First-line Treatment for MSS/pMMR Metastatic Colorectal Cancer With BRAF V600E Mutation

HAITI

β-alanine in the Treatment of Advanced Hepatocellular Carcinoma

Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab

- IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite Stable / Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Cancer Without Active Liver Metastases

Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma